Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand-Reference-Cited by-同舟云学术

Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand

Published:2023-12-20 Issue: Volume: Page:
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Pietzuch Marlena¹²,Mantel Irmela³,Ambresin Aude⁴,Tappeiner Christoph⁵⁶⁷,Nagyova Dana⁵,Donati Guy⁸,Pfister Isabel B.¹,Schild Christin¹,Garweg Justus G.¹²

Affiliation:

1. Swiss Eye Institute and Clinic for Vitreoretinal Diseases, Berner Augenklinik, Bern, Switzerland.

2. Department of Ophthalmology, Bern University Hospital, Bern, Switzerland.

3. Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Lausanne, Switzerland.

4. Swiss Visio Clinic Montchoisi, Lausanne, Switzerland.

5. Department of Ophthalmology, Pallas Kliniken, Olten, Switzerland.

6. Department of Ophthalmology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

7. Medical Faculty, University of Bern, Bern, Switzerland.

8. Centre Ophtalmologique de la Colline, Hirshlanden Clinics and Clinique d'Ophtalmologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2023.0105

Reference41 articles.

1. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis

2. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis

3. A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration

4. Disease progression pathways of wet AMD: opportunities for new target discovery

5. Progression of Lesion Size in Untreated Eyes With Exudative Age-Related Macular Degeneration